Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 1025 - 1032 of 12009 results
Commerce Department Launches Cross-Sector Consortium on AI Safety — AI: The Washington Report
February 16, 2024| Article| Viewpoint
Client Corner: Meet Co-founder & CEO of Axoft, Paul Le Floch
February 16, 2024| Podcast| Viewpoint
TikToker Drug Ads Spark Demands for FDA to Clarify Its Authority
February 16, 2024| News
Quality System Harmonization Is Here, But with Small Benefit to Device Industry
February 15, 2024| Blog| Viewpoint
Major Win for California Privacy Protection Agency: Enforcement of Regulations Can Begin Immediately
February 15, 2024| Blog| Viewpoint
USCIS Fee Increases May Have Unintended Consequences
February 15, 2024| News
Hiring Across the 49th Parallel: Traps for the Unwary for Cross-Border US-Canada Hires
February 14, 2024| Blog| Viewpoint
USCIS Online Organizational Accounts and Electronic Filing – the Future has Finally Arrived – Session 1
February 14, 2024| Webinar| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|